Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Genmab
First Affiliated Hospital of Zhejiang University
Genmab
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Fate Therapeutics
Children's Cancer Group, China
Center for International Blood and Marrow Transplant Research
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Allogene Therapeutics
Children's Oncology Group
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
University of Michigan Rogel Cancer Center
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Sana Biotechnology
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center